EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure–Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09

Timur M Garaev iD, Ilya I Yudin iD, Natalya V Breslav iD, Tatyana V Grebennikova iD, Evgenii Yu Matveev iD, Elizaveta A Eshtukova-Shcheglova iD, Ilya E Sokolov iD, Varvara V Avdeeva iD, Konstantin Yu Zhizhin iD, Nikolai T Kuznetsov

Molecules · 29.10.2025 · 30 (21) · 4225

DOI: 10.3390/molecules30214225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 29.10.2025. Verfasst von Timur M Garaev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow 123098, Russia. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza A Virus, H1N1 Subtype, Amino Acids, Boron Compounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of drug-resistant influenza virus strains necessitates the development of novel antiviral agents with unique mechanisms of action. This study presents the synthesis and in vitro evaluation of a new class of antiviral compounds: sodium salts of amino acid ester conjugates based on the closo-dodecaborate anion [B12H12]2−, linked via a tetrahydropyran-derived spacer (Na2[B12H11O(CH2)6C(O)X], where X = L-Trp-OMe (Na22); L-His-OMe (Na23); L-Met-OMe (Na24); Pld-OMe (Na25)). The antiviral activity was assessed against contemporary, multidrug-resistant influenza A virus strains, including A/Cheboksary/125/2020 (H1N1)pdm09 and A/IIV-Orenburg/83/2012 (H1N1)pdm09. Cross-platform comparison revealed that the dodecaborate-tryptophan conjugate Na22 exhibited comparable efficacy to its lead decaborate analog against the Orenburg strain while demonstrating potent activity (IC50 = 5.0 µg/mL) against the Cheboksary strain with reduced susceptibility to neuraminidase inhibitors (oseltamivir; zanamivir) and complete resistance to M2 channel blockers. The histidine-based conjugate Na23 also showed significant efficacy against the Cheboksary strain, while methionine and lactam derivatives (Na24; Na25) remained inactive. This work confirms boron clusters as versatile platforms for antiviral development and establishes structure–activity relationships crucial for optimizing both B10 and B12-based therapeutics against resistant influenza strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInfluenza A Virus, H1N1 SubtypeAmino AcidsBoron CompoundsBoratesStructure-Activity RelationshipHumansInfluenza, HumanMicrobial Sensitivity TestsNeuraminidaseAnimalsDogsMadin Darby Canine Kidney Cells

Stichwörter der Autor:innen

amino acidsantiviral activitycloso-dodecaborate anionopening of cyclic substituentspolyhedral boron anionstetrahydropyranviroporins

Substanzen

Antiviral AgentsAmino AcidsBoron CompoundsNeuraminidaseBorates

Autor:innen und Institutionen

  • Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow 123098, Russia.
  • Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow 119991, Russia.
  • Institute of Fine Chemical Technologies named after M. V. Lomonosov, MIREA-Russian Technological University, Moscow 119571, Russia.
  • Federal Research Centre of Nutrition and Biotechnology, Moscow 109240, Russia.

ORCID-Profile: Timur M Garaev, Ilya I Yudin, Natalya V Breslav, Tatyana V Grebennikova, Evgenii Yu Matveev, Elizaveta A Eshtukova-Shcheglova, Ilya E Sokolov, Varvara V Avdeeva, Konstantin Yu Zhizhin

Förderung

  • Russian Science Foundation

Zitieren

APA

Garaev, T. M., Yudin, I. I., Breslav, N. V., Grebennikova, T. V., Matveev, E. Y., Eshtukova-Shcheglova, E. A., Sokolov, I. E., Avdeeva, V. V., Zhizhin, K. Y., & Kuznetsov, N. T. (2025). Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure–Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09. Molecules, 30(21), 4225. https://doi.org/10.3390/molecules30214225

Vancouver

Garaev TM, Yudin II, Breslav NV, Grebennikova TV, Matveev EY, Eshtukova-Shcheglova EA, et al. Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure–Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09. Molecules. 2025;30(21):4225. doi:10.3390/molecules30214225

BibTeX
@article{Garaev2025,
  author = {Garaev, Timur M and Yudin, Ilya I and Breslav, Natalya V and Grebennikova, Tatyana V and Matveev, Evgenii Yu and Eshtukova-Shcheglova, Elizaveta A and Sokolov, Ilya E and Avdeeva, Varvara V and Zhizhin, Konstantin Yu and Kuznetsov, Nikolai T},
  title = {Exploring the Anti-Influenza Activity of closo-Borate Platforms: Structure–Activity Relationship of Amino Acid-Functionalized closo-Dodecaborate Derivatives Against Influenza Virus A/Cheboksary/125/2020 (H1N1)pdm09},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {21},
  pages = {4225},
  doi = {10.3390/molecules30214225}
}
Kostenlos starten →